| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 706401 | 79828 | BOSENTAN ACCORDPHARMA 62,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSENTAN ACCORDPHARMA 62,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos (Blister PVC/PE/PVDC/AL) | 62,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79828/79828_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79828/79828_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2015-05-11 | 1 | 1 | 1 | 2015-05-11 | 2015-05-11 | 1 | 2015-10-14 | View Edit Delete | ||||||||||||
| 707732 | 80171 | BOSENTAN NORMON 62,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSENTAN NORMON 62,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos (Blister Al/PVDC/PE) | 62,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80171/80171_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80171/80171_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2015-09-24 | 1 | 1 | 1 | 2015-09-24 | 2015-09-24 | 0 | 2017-11-06 | View Edit Delete | ||||||||||||
| 707734 | 80172 | BOSENTAN NORMON 125 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSENTAN NORMON 125 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos (Blister Al/PVDC/PE) | 125 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80172/80172_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80172/80172_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2015-09-24 | 1 | 1 | 1 | 2015-09-24 | 2015-09-24 | 0 | 2017-11-06 | View Edit Delete | ||||||||||||
| 707788 | 80200 | VORICONAZOL NORMON 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VORICONAZOL NORMON 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos (Blister aluminio/PVC) | 50 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80200/80200_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80200/80200_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2015-09-24 | 1 | 1 | 1 | 2015-09-24 | 2015-09-24 | 1 | 2016-07-14 | View Edit Delete | ||||||||||||
| 708654 | 80410 | OXICODONA/NALOXONA STADA 10 MG/5 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | OXICODONA/NALOXONA STADA 10 MG/5 MG COMPRIMIDO DE LIBERACION PROLONGADA EFG, 56 comprimidos | 10 mg/5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80410/80410_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80410/80410_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2016-12-23 | 1 | 1 | 1 | 2016-12-23 | 2016-12-23 | 0 | 2018-09-21 | Lista I | View Edit Delete | |||||||||||
| 708668 | 80411 | OXICODONA/NALOXONA STADA 20 MG/10 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | OXICODONA/NALOXONA STADA 20 MG/10 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 56 comprimidos | 20 mg/10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80411/80411_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80411/80411_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2016-12-23 | 1 | 1 | 1 | 2016-12-23 | 2016-12-23 | 0 | 2018-09-21 | Lista I | View Edit Delete | |||||||||||
| 708686 | 80412 | OXICODONA/NALOXONA STADA 30 MG/15 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | OXICODONA/NALOXONA STADA 30 MG/15 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 56 comprimidos | 30 mg/15 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80412/80412_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80412/80412_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2016-12-23 | 1 | 1 | 1 | 2016-12-23 | 2016-12-23 | 0 | 2020-11-06 | Lista I | View Edit Delete | |||||||||||
| 708703 | 80413 | OXICODONA/NALOXONA STADA 40 MG/20 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | OXICODONA/NALOXONA STADA 40 MG/20 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 56 comprimidos | 40 mg/20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80413/80413_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80413/80413_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2016-12-23 | 1 | 1 | 1 | 2016-12-23 | 2016-12-23 | 0 | 2018-09-21 | Lista I | View Edit Delete | |||||||||||
| 708717 | 80414 | OXICODONA/NALOXONA STADA 5 MG/2,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | OXICODONA/NALOXONA STADA 5 MG/2,5 MG COMPRIMIDO DE LIBERACION PROLONGADA EFG, 56 comprimidos | 5 mg/2,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80414/80414_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80414/80414_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2016-12-23 | 1 | 1 | 1 | 2016-12-23 | 2016-12-23 | 0 | 2018-09-21 | Lista I | View Edit Delete | |||||||||||
| 706636 | 112773015 | JAKAVI 10 MG COMPRIMIDOS | JAKAVI 10 MG COMPRIMIDOS, 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112773015/112773015_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112773015/112773015_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2015-05-29 | 1 | 1 | 1 | 2015-05-29 | 2015-05-29 | 1 | 2016-03-01 | View Edit Delete | ||||||||||||
| 707228 | 80073 | BOSENTAN KERN PHARMA 62,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSENTAN KERN PHARMA 62,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 62,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80073/80073_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80073/80073_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2015-07-30 | 1 | 1 | 1 | 2015-07-30 | 2015-07-30 | 0 | 2015-10-14 | View Edit Delete | ||||||||||||
| 708311 | 80339 | MEMANTINA TEVA-RATIOPHARM 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | MEMANTINA TEVA-RATIOPHARM 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80339/80339_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80339/80339_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2015-10-29 | 1 | 1 | 1 | 2015-10-29 | 2015-10-29 | 1 | 2020-01-14 | View Edit Delete | ||||||||||||
| 708252 | 113832001 | STAYVEER 62,5mg comprimidos recubiertos con pelicula | STAYVEER 62,5mg comprimidos recubiertos con pelicula 56 comprimidos | 62,5 MG | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113832001/113832001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113832001/113832001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | JANSSEN CILAG S.A. | 2015-10-21 | 1 | 1 | 1 | 2015-10-21 | 2015-10-21 | 1 | 2016-04-11 | View Edit Delete | ||||||||||||
| 708253 | 113832002 | STAYVEER 125 mg comprimidos recubiertos con pelicula | STAYVEER 125 mg comprimidos recubiertos con pelicula 56 COMPRIMIDOS | 125 mg | 5 | 56 | 10 | 56 COMPRIMIDOS | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113832002/113832002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113832002/113832002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | JANSSEN CILAG S.A. | 2015-10-21 | 1 | 1 | 1 | 2015-10-21 | 2015-10-21 | 1 | 2016-04-11 | View Edit Delete | ||||||||||||
| 710007 | 02219027IP | EBIXA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EBIXA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02219027IP/02219027IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02219027IP/02219027IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1250 | ELAM PHARMA LABS S.L. | 2016-02-16 | 1 | 1 | 1 | 2016-02-16 | 2016-02-16 | 1 | 2016-08-04 | View Edit Delete | ||||||||||||
| 709177 | 1151058003 | ENTRESTO 49 MG/51 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ENTRESTO 49 MG/51 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos | 49 mg/51 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151058003/1151058003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151058003/1151058003_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2015-12-11 | 1 | 1 | 1 | 2015-12-11 | 2015-12-11 | 0 | 2016-09-02 | View Edit Delete | ||||||||||||
| 709178 | 1151058006 | ENTRESTO 97 MG/103 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ENTRESTO 97 MG/103 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos | 97 mg/103 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151058006/1151058006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151058006/1151058006_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2015-12-11 | 1 | 1 | 1 | 2015-12-11 | 2015-12-11 | 0 | 2016-09-02 | View Edit Delete | ||||||||||||
| 711005 | 75226 | ESCITALOPRAM VISO FARMACEUTICA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ESCITALOPRAM VISO FARMACEUTICA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG,56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75226/75226_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75226/75226_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2013-04-16 | 1 | 1 | 1 | 2013-04-16 | 2016-05-23 | 1 | 2016-06-02 | View Edit Delete | ||||||||||||
| 711006 | 75224 | ESCITALOPRAM VISO FARMACEUTICA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ESCITALOPRAM VISO FARMACEUTICA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG,56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75224/75224_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75224/75224_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2013-04-16 | 1 | 1 | 1 | 2013-04-16 | 2016-05-23 | 1 | 2016-06-02 | View Edit Delete | ||||||||||||
| 711007 | 75225 | ESCITALOPRAM VISO FARMACEUTICA 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ESCITALOPRAM VISO FARMACEUTICA 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG,56 comprimidos | 15 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75225/75225_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75225/75225_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2013-04-16 | 1 | 1 | 1 | 2013-04-16 | 2016-05-23 | 1 | 2016-06-02 | View Edit Delete |
Page 138 of 1035, showing 20 records out of 20697 total, starting on record 2741, ending on 2760